Russian high-risk cores decided to be left without drugs

A matter of life and death - 1.8 billion rubles

We are speakme about an order that yearly approves a listing of medication to provide outpatients who have suffered acute cerebrovascular coincidence, myocardial infarction, and who underwent coronary artery skip grafting, angioplasty of the coronary arteries with stenting and catheter ablation for cardiovascular illnesses. 

Russian high-risk cores decided to be left without drugs Today there are 23 drugs on the listing, next yr it become planned to increase it to 33, however, a whole group of medication from the institution of so-called. PCSK9 inhibitors have been not protected in the draft new list. At the same time, the medicine protected in this institution are existence-saving for human beings with atherosclerotic cardiovascular sickness (which includes myocardial infarction, acute cerebrovascular accident), for the reason that they notably lessen the probability of repeated vascular accidents and deaths through reducing low-density lipoprotein ldl cholesterol.Russian News,Russian News live, News 24/7

In nations wherein they're vastly used to deal with cardiovascular sicknesses and save you coronary heart assaults and strokes, a good sized lower in cardiovascular mortality is recorded. Thus, in patients with earlier acute coronary syndrome (ACS), the usage of PCSK9 inhibitors reduces the threat of fundamental cardiovascular events, including death from coronary heart sickness, non-fatal myocardial infarction, deadly and non-deadly ischemic stroke, or unstable angina requiring hospitalization by 15%. At the identical time, doctors notice that the very best chance of deaths is in patients after ACS, frequently of working age, with extreme hypercholesterolemia (extra than 5 mmol/l). One in 5 of them, in line with worldwide studies, can die inside 2.Eight years if the proper therapy isn't always began.Russian News,Russian News live, News 24/7

“The frequency of coronary heart assaults and strokes in the united states has been declining for greater than 10 years, but still stays high,” said MK, Doctor of Medical Sciences, Professor, Chief Researcher at the Department of Atherosclerosis Problems, Head of the Laboratory of Lipid Metabolism Disorders, Cardiologist, President National Society for the Study of Atherosclerosis Marat Yezhov. - Even after receiving high-tech medical care, for 2 years, patients continue to be at high chance for cardiovascular disease and want therapy to decrease and manipulate ldl cholesterol. Statins are available to them, but no longer all of them assist to decrease cholesterol to the favored degree. The most tolerated dose isn't always continually powerful. And this is a direct indication for mixture therapy and a very justified area of interest for the usage of PCSK9 inhibitors, the maximum important magnificence of drugs who got here to cardiology from rheumatology and oncology. What does this imply, in easy terms? This is a targeted remedy for the seize by way of hepatocytes (liver cells) of "terrible" cholesterol from the bloodstream in human beings. Thus, there may be a obligatory and reported lower inside the degree of "terrible" ldl cholesterol or low-density lipoprotein ldl cholesterol. This is the most modern and safe intensive remedy against hyperlipidemia and atherosclerosis that exists nowadays, which has already been shown through 8 years of enjoy in its use in cardiology. Unfortunately, in the meanwhile they may be no longer part of the federal drug program for excessive-risk CVD patients, however this is still problem to change.” in easy phrases? This is a focused therapy for the seize by means of hepatocytes (liver cells) of "awful" cholesterol from the bloodstream in humans. Thus, there is a obligatory and mentioned lower within the stage of "awful" cholesterol or low-density lipoprotein cholesterol. This is the maximum current and secure in depth therapy against hyperlipidemia and atherosclerosis that exists these days, which has already been proven by eight years of experience in its use in cardiology. Unfortunately, in the interim they're no longer a part of the federal drug program for excessive-risk CVD sufferers, however that is nonetheless challenge to change.” in simple phrases? This is a focused remedy for the seize by means of hepatocytes (liver cells) of "bad" cholesterol from the bloodstream in human beings. Thus, there may be a mandatory and suggested decrease within the level of "horrific" cholesterol or low-density lipoprotein cholesterol. This is the most cutting-edge and secure intensive remedy towards hyperlipidemia and atherosclerosis that exists today, which has already been shown by using eight years of revel in in its use in cardiology. Unfortunately, in the meanwhile they are not a part of the federal drug program for high-danger CVD patients, however this is nonetheless challenge to alternate.” This is the most modern-day and safe in depth therapy in opposition to hyperlipidemia and atherosclerosis that exists these days, which has already been proven by means of eight years of enjoy in its use in cardiology. Unfortunately, at the moment they are not a part of the federal drug program for high-risk CVD patients, however this is nevertheless difficulty to trade.” This is the most modern and secure intensive remedy in opposition to hyperlipidemia and atherosclerosis that exists today, which has been shown with the aid of eight years of enjoy in its use in cardiology. Unfortunately, for the time being they're now not protected inside the federal drug program for high-danger CVD sufferers, but this is nonetheless problem to change.”Russian News,Russian News live, News 24/7

“We are speaking approximately a big institution of patients who want preferential drug insurance. The All-Russian Union of Patients is making ready practical proposals for the authorities, which includes the allocation of extra investment for drugs for sufferers with CVD. It is vital to introduce preferential provision of medicines for sufferers stricken by coronary coronary heart disorder in aggregate with comorbid conditions, in addition to sufferers with hypercholesterolemia,” says Yury Zhulyov, co-chairman of the All-Russian Union of Patients.Facebook Bio, Fb bio 2023,  

“Despite the qualitative modifications, the trouble of the provision of drug treatments and diagnostics continues to be inside the “pinnacle problems” for patients. We hoped that the situation would improve this 12 months, but to date the improvements had been specially for patients with advantages, ”says Yan Vlasov, co-chairman of the All-Russian Union of Patients. According to Vlasov, the want for additional funding for drug provision of excessive-risk sufferers is 1.Eight billion rubles. And this money will seriously reduce mortality from diseases of the circulatory machine and boom common existence expectancy.Facebook Bio, Fb bio 2023,